Sean Diver ist neuer DCAT-Präsident

DCAT is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

Sean Diver has been in the pharmaceutical industry for over 30 years, having served technical and commercial leadership roles for both innovator companies and CDMOs.

Mr. Diver holds a B.S. in Chemical Engineering from Lehigh University. He started his career in 1989 at Merck & Co. from where he moved to BD Medical in 200 and Lonza in 2001. From 2007 to 2013, the US-American worked for several years for Dr. Reddy's, Cambridge Major Laboratories and Zach Systems before returning to Lonza in 2014. Currently, he is Director of Commercial Development in the Lonza Pharma Biotech & Nutrition Segment at Lonza focused on late-stage, small-molecule drug substances.

Mr. Diver has been an active member of DCAT for many years by participating on various committees, including serving as chair of the DCAT Technology Committee, as a member of the Advisory Council, and as a member of the Board of Directors.